Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Early 18F-FDG PET/CT response predicts survival in Relapsed/Refractory Hodgkin Lymphoma treated with Nivolumab.

Chen A, Mokrane FZ, Schwartz L, Morschhauser F, Stamatoullas A, Schiano de Colella JM, Vercellino L, Casasnovas O, Chauchet A, Delmer A, Nicolas-Virelizier E, Ghesquières H, Moles-Moreau MP, Schmitt A, Dulery R, Bouabdallah K, Borel C, Touati M, Deau-Fischer B, Peyrade F, Seban RD, Manson G, Armand P, Houot R, Dercle L.

J Nucl Med. 2019 Oct 18. pii: jnumed.119.232827. doi: 10.2967/jnumed.119.232827. [Epub ahead of print]

PMID:
31628220
2.

Radiotherapy in combination with nivolumab for relapsed/refractory classical Hodgkin lymphoma: About two cases.

de Forceville L, Deau-Fischer B, Franchi P, Arsène-Henry A, Cassou Mounat T, Bouscary D, Kirova YM.

Cancer Radiother. 2019 Jun;23(3):232-239. doi: 10.1016/j.canrad.2018.12.005. Epub 2019 May 27.

PMID:
31147173
3.

High-dose chemotherapy without transfusion for Philadelphia chromosome negative B-cell acute lymphoblastic leukemia in two Jehovah's Witnesses patients: a feasible option in the age of hematopoietic growth factors.

Perol L, Grignano E, Contejean A, Gastaud L, Legoff M, Franchi P, Deau-Fischer B, Willems L, Bouscary D, Tamburini J.

Leuk Lymphoma. 2019 Sep;60(9):2324-2327. doi: 10.1080/10428194.2019.1577414. Epub 2019 Feb 18. No abstract available.

PMID:
30773115
4.

T-cell large granular lymphocyte leukemia transfomation into aggressive T-cell lymphoma: a report of two cases with molecular characterization.

Belhadj M, Mansour D, Kaltenbach S, Deau-Fischer B, Franchi P, Tamburini J, Chapuis N, Damotte D, Kosmider O, Burroni B, Bouscary D.

Haematologica. 2019 Mar;104(3):e117-e120. doi: 10.3324/haematol.2018.205542. Epub 2018 Dec 20. No abstract available.

5.

Radiotherapy of relapse-refractory follicular lymphoma.

Grignano É, Deau-Fischer B, Loganadane G, Breton M, Burroni B, Bouscary D, Kirova YM.

Cancer Radiother. 2018 Apr;22(2):126-130. doi: 10.1016/j.canrad.2017.09.003. Epub 2018 Feb 22.

PMID:
29477304
6.

Our experience of solitary plasmacytoma of the bone: improved PFS with a short-course treatment by IMiDs or proteasome inhibitors combined with intensity-modulated radiotherapy.

Le Ray E, Belin L, Plancher C, Anract P, Babinet A, Dumaine V, Tamburini J, Deau Fischer B, Willems L, Magro L, Facon T, Leleu X, Bouscary D, Kirova YM.

Leuk Lymphoma. 2018 Jul;59(7):1756-1758. doi: 10.1080/10428194.2017.1393667. Epub 2017 Oct 31. No abstract available.

PMID:
29087212
7.

Uterine intravascular lymphoma as a cause of fever of unknown origin.

Hadjadj J, Nielly H, Piekarski E, Cuccuini W, Deau-Fischer B, Hourseau M, Benali K, Fieschi C, Aletti M, Papo T, Oksenhendler E, Galicier L, Boutboul D.

Ann Hematol. 2017 Nov;96(11):1891-1896. doi: 10.1007/s00277-017-3117-4. Epub 2017 Aug 29. Review.

PMID:
28852831
8.

In Situ Hepatitis C NS3 Protein Detection Is Associated with High Grade Features in Hepatitis C-Associated B-Cell Non-Hodgkin Lymphomas.

Canioni D, Michot JM, Rabiega P, Molina TJ, Charlotte F, Lazure T, Davi F, Settegrana C, Berger F, Alric L, Cacoub P, Terrier B, Suarez F, Sibon D, Dupuis J, Feray C, Tilly H, Pol S, Deau Fischer B, Roulland S, Thieblemont C, Leblond V, Carrat F, Hermine O, Besson C; national ANRS HC13 LymphoC study.

PLoS One. 2016 Jun 3;11(6):e0156384. doi: 10.1371/journal.pone.0156384. eCollection 2016.

9.

Single or tandem autologous stem-cell transplantation for first-relapsed or refractory Hodgkin lymphoma: 10-year follow-up of the prospective H96 trial by the LYSA/SFGM-TC study group.

Sibon D, Morschhauser F, Resche-Rigon M, Ghez D, Dupuis J, Marçais A, Deau-Fischer B, Bouabdallah R, Sebban C, Salles G, Brice P.

Haematologica. 2016 Apr;101(4):474-81. doi: 10.3324/haematol.2015.136408. Epub 2015 Dec 31.

10.

Hepatitis E transmission by transfusion of Intercept blood system-treated plasma.

Hauser L, Roque-Afonso AM, Beylouné A, Simonet M, Deau Fischer B, Burin des Roziers N, Mallet V, Tiberghien P, Bierling P.

Blood. 2014 Jan 30;123(5):796-7. doi: 10.1182/blood-2013-09-524348. No abstract available.

PMID:
24482503
11.

Enteropathy-associated T-cell lymphoma: a review on clinical presentation, diagnosis, therapeutic strategies and perspectives.

Chandesris MO, Malamut G, Verkarre V, Meresse B, Macintyre E, Delarue R, Rubio MT, Suarez F, Deau-Fischer B, Cerf-Bensussan N, Brousse N, Cellier C, Hermine O.

Gastroenterol Clin Biol. 2010 Nov;34(11):590-605. doi: 10.1016/j.gcb.2010.09.008. Epub 2010 Nov 2. Review.

12.

Rapamycin for refractory acute graft-versus-host disease.

Ghez D, Rubio MT, Maillard N, Suarez F, Chandesris MO, Delarue R, Deau-Fischer B, Varet B, Hermine O, Buzyn A.

Transplantation. 2009 Nov 15;88(9):1081-7. doi: 10.1097/TP.0b013e3181ba0a13.

PMID:
19898203
13.

Prognostic significance of new immunohistochemical markers in refractory classical Hodgkin lymphoma: a study of 59 cases.

Canioni D, Deau-Fischer B, Taupin P, Ribrag V, Delarue R, Bosq J, Rubio MT, Roux D, Vasiliu V, Varet B, Brousse N, Hermine O.

PLoS One. 2009 Jul 22;4(7):e6341. doi: 10.1371/journal.pone.0006341.

Supplemental Content

Loading ...
Support Center